drugset / Trial / NCT05087264

Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer

NCT05087264

RandomizedParallel-groupOpen-labelTreatment

Summary

Indocyanine green was injected intravenously into patients with cervical cancer before operation. The nerve development was observed by infrared imaging system during operation, which was used as the basis for nerve preserving operation of type C cervical cancer. The recovery of bladder function was observed.

Timeline

Start
2022-03-10
Primary completion
2025-10-16
Completion
2025-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.5 unknown Intravenous
Subject Indocyanine Green Diagnostic / imaging agent 25 mg Intravenous

Indications